Having trouble accessing articles? Reset your cache.

Cubist sells $400M in notes

Cubist Pharmaceuticals Inc. (NASDAQ:CBST) raised $400 million in a bumped-up offering of

Read the full 125 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE